CSIMarket
 


Acorda Therapeutics Inc   (ACOR)
Other Ticker:  
 
 

Acorda Therapeutics Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Acorda Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 9.18, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2023. Average collection period, for Acorda Therapeutics Inc 's accounts receivable remained unchanged at 40 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 399 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 2664 to 2687.

What is Receivable Turnover Ratio?
What is Acorda Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




ACOR Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change -18.47 % -6.17 % -23.35 % -18.44 % 8.12 %
Y / Y Revenue Change -17.3 % -4.43 % -1.22 % -14.87 % 6.53 %
Receivable Turnover Ratio (TTM) 9.18 9.15 9.1 8.65 8.56
ACOR's Total Ranking # 2687 # 2664 # 1382 # 2337 # 1973
Average receivable collection period 40 40 40 42 43
Seq. Receivable Change -10.55 % 45.7 % -33.72 % -5.61 % 2.94 %
Seq. Revenue Change -6.6 % 33.32 % -29.27 % -6.09 % 7.92 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 27
Healthcare Sector # 400
Overall Market # 2687

Receivable Turnover Ratio Statistics
High Average Low
0.58 0.36 0.19
(March 31, 2014)   (Dec 31 2019)






Financial Statements
Acorda Therapeutics Inc 's Accounts Receivable $ 12 Millions Visit ACOR's Balance sheet
Acorda Therapeutics Inc 's Sales TTM $ 111 Millions Visit ACOR's Income Statement
Where are ACOR's Sales coming from? Visit ACOR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ACOR's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for ACOR's Competitors
Receivables Turnover Ratio for ACOR's Suppliers
Accounts Receivables Turnover Ratio for ACOR's Customers

You may also want to know
ACOR's Growth Rates ACOR's Roa ACOR's Inventory Turnover Ratio ACOR's Dividend Comparisons
ACOR's Profitability Ratios ACOR's Roi ACOR's Asset Turnover Ratio ACOR's Dividend Growth
ACOR's Valuation Ratios ACOR's Roe ACOR's Financial Strength Ratios ACOR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Voyager Therapeutics Inc   25.34 $ 158.398  Millions$ 6.250  Millions
Neuroone Medical Technologies Corporation  25.25 $ 1.952  Millions$ 0.077  Millions
Cue Health Inc   25.20 $ 198.915  Millions$ 7.894  Millions
Adaptimmune Therapeutics Plc  23.54 $ 75.969  Millions$ 3.227  Millions
Molecular Templates inc   23.22 $ 18.064  Millions$ 0.778  Millions
Qilian International Holding Group Limited  23.16 $ 45.751  Millions$ 1.976  Millions
Cv Sciences Inc   23.08 $ 15.578  Millions$ 0.675  Millions
C4 Therapeutics Inc   23.06 $ 20.349  Millions$ 0.882  Millions
Vaxart Inc   22.56 $ 4.156  Millions$ 0.184  Millions
Mymetics Corporation  21.62 $ 1.229  Millions$ 0.057  Millions
Ontrak Inc   21.60 $ 11.674  Millions$ 0.541  Millions
Pieris Pharmaceuticals Inc   21.38 $ 47.357  Millions$ 2.216  Millions
Kiniksa Pharmaceuticals ltd   20.83 $ 248.748  Millions$ 11.944  Millions
Invo Bioscience Inc   20.81 $ 1.917  Millions$ 0.092  Millions
U S Physical Therapy Inc  20.64 $ 360.180  Millions$ 17.452  Millions
Marizyme Inc   19.60 $ 0.591  Millions$ 0.030  Millions
Innovage Holding Corp   19.18 $ 699.354  Millions$ 36.470  Millions
Xoma Corporation  18.55 $ 4.411  Millions$ 0.238  Millions
Plus Therapeutics Inc   18.55 $ 3.751  Millions$ 0.202  Millions
Cano Health Inc   18.50 $ 3,101.906  Millions$ 167.675  Millions
Tivic Health Systems Inc   18.42 $ 1.331  Millions$ 0.072  Millions
Qhslab Inc   17.62 $ 1.362  Millions$ 0.077  Millions
Arvinas Inc   17.55 $ 167.200  Millions$ 9.525  Millions
Recursion Pharmaceuticals Inc   17.18 $ 47.360  Millions$ 2.756  Millions
Ocuphire Pharma Inc   15.89 $ 57.208  Millions$ 3.600  Millions
Lftd Partners Inc   15.79 $ 49.404  Millions$ 3.129  Millions
Comera Life Sciences Holdings Inc   15.42 $ 1.096  Millions$ 0.071  Millions
Chemed Corporation  15.30 $ 2,225.159  Millions$ 145.392  Millions
Patterson Companies Inc   14.56 $ 6,550.083  Millions$ 449.864  Millions
Talkspace Inc   14.24 $ 137.071  Millions$ 9.623  Millions

Date modified: 2023-11-16T19:19:22+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com